raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:206546

Symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers

Type
Disease
Group
Disorder
Inheritance
X-linked recessive
Age of onset
Adult
Status
active

A rare, genetic muscular dystrophy affecting female carriers and characterized by variable degrees of muscle weakness due to progressive skeletal myopathy, sometimes associated with dilated cardiomyopathy or left ventricle dilation.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enSymptomatic form of muscular dystrophy of Duchenne and Becker in female carriers
frForme symptomatique de la dystrophie musculaire de Duchenne et Becker de la femme porteuse
deSymptomatische Form der Muskeldystrophie Duchenne und Becker in weiblichen Trägerinnen
esForma sintomática de la distrofia muscular de Duchenne y Becker en mujeres portadoras
itForma sintomatica della distrofia muscolare di Duchenne e di Becker nelle femmine portatrici
nlSymptomatische vorm van spierdystrofie van Duchenne en Becker bij vrouwelijke dragers
ptForma sintomática de distrofia muscular de Duchenne e Becker em portadoras
plObjawowa postać dystrofii mięśniowej Duchenne'a i Beckera u kobiet nosicielek
csSymptomatická forma Duchenovy a Beckerovy svalové dystrofie u žen přenašeček
ukСимптоматична форма мязової дистрофії Дюшена і Беккера у жінок-носіїв
zh女性Duchenne型和Becker型肌营养不良症携带者症候
trKadın taşıyıcılarda Duchenne ve Becker kas distrofisi semptomatik formu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10G71.0NTBTattributedvalidated
ICD-118C70.0BTNTspecificvalidated
ICD-118C70.1BTNTspecificvalidated
MONDO0016097Evalidated
UMLSC4707359Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
DMDDisease-causing germline mutation(s) inAssessedHGNC:2928ENSG00000198947300377Xp21.2-p21.1dystrophin
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—WorldwideClass onlyNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

20 annotations · validated 2021-12-02
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0003236Elevated circulating creatine kinase concentration
HP:0002938Lumbar hyperlordosis
HP:0003701Proximal muscle weakness
Occasional (29-5%)
HP:0001435Abnormality of the shoulder girdle musculature
HP:0030097Absent muscle dystrophin expression
HP:0008981Calf muscle hypertrophy
HP:0001644Dilated cardiomyopathy
HP:0003710Exercise-induced muscle cramps
HP:0003324Generalized muscle weakness
HP:0002540Inability to walk
HP:0001712Left ventricular hypertrophy
HP:0003394Muscle spasm
HP:0003326Myalgia
HP:0003731Quadriceps muscle weakness
HP:0002942Thoracic kyphosis
HP:0002943Thoracic scoliosis
Very rare (<4-1%)
HP:0001635Congestive heart failure
HP:0002987Elbow flexion contracture
Excluded (0%)
HP:0003409Distal sensory impairment of all modalities
HP:0002380Fasciculations

Annotation source: 32022138 [PMID]_20301298[PMID]

7

Sources for this card